World's Best Scientists 2026 revealed!
Anthony P. Adamis

Anthony P. Adamis

D-Index & Metrics

Medicine

D-Index
94
Citations
46338
World Ranking
10283
National Ranking
5287

Research.com Recognitions

  • 2019 - Member of the National Academy of Medicine (NAM)

Overview

Anthony P. Adamis is affiliated with Genentech in the United States and is primarily engaged in medical research focused on ophthalmology. Their work spans several subfields including ophthalmology and radiology, nuclear medicine, and imaging. The primary area of study involves retinal diseases and treatments, with related attention to retinal imaging and analysis, glaucoma and retinal disorders, retinopathy of prematurity studies, retinal and macular surgery, and other retinal and optic conditions.

Recent publications reflect their engagement in advancing knowledge on retinal disorders and therapeutic approaches. Notable papers include:

  • "Archway Randomized Phase 3 Trial of the Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration" (2021, Ophthalmology)
  • "Building on the success of anti-vascular endothelial growth factor therapy: a vision for the next decade" (2020, Eye)
  • "Rationale of Basic and Cellular Mechanisms Considered in Updating the Staging System for Diabetic Retinal Disease" (2024, Ophthalmology Science)
  • "Contents" (2022, Ophthalmology)
  • "Feasibility demonstration of a device for vitreous liquid biopsy incidental to intravitreal injection" (2024, PLoS ONE)

Anthony P. Adamis has collaborated frequently with several researchers in the field. Frequent co-authors include:

  • Christopher Brittain
  • Peter A. Campochiaro
  • Margaret Chang
  • Daniel M. Miller
  • Dante J. Pieramici

Their work is published primarily in the following venues:

  • Ophthalmology
  • Eye
  • Ophthalmology Science
  • PLoS ONE

Anthony P. Adamis has produced research predominantly in the field of medicine with a strong focus on retinal diseases and related imaging techniques. These areas are reflected in the main topics of their research:

  • Retinal Diseases and Treatments
  • Retinal Imaging and Analysis
  • Glaucoma and retinal disorders
  • Retinal and Optic Conditions
  • Retinopathy of Prematurity Studies
  • Retinal and Macular Surgery

They have received recognition as a member of the National Academy of Medicine since 2019.

Best Publications

  • Pegaptanib for neovascular age-related macular degeneration

    E.S. . Gragoudas;A.P. Adamis;E.T. Cunningham;M. Feinsod

  • Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease

    Eugene W. M. Ng;David T. Shima;Perry Calias;Emmett T. Cunningham

  • Increased Vascular Endothelial Growth Factor Levels in the Vitreous of Eyes With Proliferative Diabetic Retinopathy

    Anthony P. Adamis;Anthony P. Adamis;Joan W. Miller;Maria-Teresa Bernal;Donald J. D'Amico

  • A central role for inflammation in the pathogenesis of diabetic retinopathy

    Antonia M. Joussen;Vassiliki Poulaki;Minh Ly Le;Kan Koizumi

  • Age-related macular degeneration: etiology, pathogenesis, and therapeutic strategies.

    Jayakrishna Ambati;Jayakrishna Ambati;Balamurali K Ambati;Balamurali K Ambati;Sonia H Yoo;Sonia H Yoo;Sean Ianchulev

  • Ten years of anti-vascular endothelial growth factor therapy

    Napoleone Ferrara;Anthony P. Adamis

  • Long-term outcomes of ranibizumab therapy for diabetic macular edema: the 36-month results from two phase III trials: RISE and RIDE.

    David M. Brown;Quan Dong Nguyen;Dennis M. Marcus;David S. Boyer

  • Prevention of leukostasis and vascular leakage in streptozotocin-induced diabetic retinopathy via intercellular adhesion molecule-1 inhibition

    Kazuaki Miyamoto;Samer Khosrof;Sven-Erik Bursell;Richard Rohan

  • Vascular endothelial growth factor/vascular permeability factor is temporally and spatially correlated with ocular angiogenesis in a primate model.

    Joan W. Miller;Anthony P. Adamis;David T. Shima;Patricia A. D'Amore

  • Vascular endothelial growth factor-A is a survival factor for retinal neurons and a critical neuroprotectant during the adaptive response to ischemic injury.

    Kazuaki Nishijima;Yin-Shan Ng;Lichun Zhong;John Bradley

  • A phase II randomized double-masked trial of pegaptanib, an anti-vascular endothelial growth factor aptamer, for diabetic macular edema.

    Emmett T Cunningham;Anthony P Adamis;Michael Altaweel;Lloyd P Aiello

  • Inhibition of vascular endothelial growth factor prevents retinal ischemia-associated iris neovascularization in a nonhuman primate

    Anthony P. Adamis;David T. Shima;Michael J. Tolentino;Evangelos S. Gragoudas

  • Prevention of experimental choroidal neovascularization with intravitreal anti-vascular endothelial growth factor antibody fragment.

    Magdalena G. Krzystolik;Mehran A. Afshari;Anthony P. Adamis;Jacques Gaudreault

  • Leukocyte-Mediated Endothelial Cell Injury and Death in the Diabetic Retina

    Antonia M. Joussen;Toshinori Murata;Toshinori Murata;Akitaka Tsujikawa;Akitaka Tsujikawa;Bernd Kirchhof

  • Nonsteroidal anti-inflammatory drugs prevent early diabetic retinopathy via TNF-alpha suppression.

    Antonia M. Joussen;Vassiliki Poulaki;Nicholas Mitsiades;Bernd Kirchhof

  • VEGF INHIBITION STUDY IN OCULAR NEOVASCULARIZATION CLINICAL TRIAL GROUP. PEGAPTANIB FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION

    E S Gragoudas;A P Adamis;E T Cunningham;M Feinsod

  • VEGF-initiated blood-retinal barrier breakdown in early diabetes.

    Tamim Qaum;Qingwen Xu;Antonia M. Joussen;Mark W. Clemens

  • INTRAVITREOUS INJECTIONS OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCE RETINAL ISCHEMIA AND MICROANGIOPATHY IN AN ADULT PRIMATE

    Michael J. Tolentino;Michael J. Tolentino;Joan W. Miller;Evangelos S. Gragoudas;Frederick A. Jakobiec

  • Sustained benefits from ranibizumab for macular edema following branch retinal vein occlusion: 12-month outcomes of a phase III study.

    David M. Brown;Peter A. Campochiaro;Robert B. Bhisitkul;Allen C. Ho

  • Ocular neovascularization: an epidemiologic review.

    Patricia Lee;Cindy C. Wang;Anthony P. Adamis

Frequent Co-Authors

Joan W. Miller
Joan W. Miller Massachusetts Eye and Ear Infirmary
Evangelos S. Gragoudas
Evangelos S. Gragoudas Massachusetts Eye and Ear Infirmary
Shiro Amano
Shiro Amano University of Tokyo
Patricia A. D'Amore
Patricia A. D'Amore Massachusetts Eye and Ear Infirmary
Judah Folkman
Judah Folkman Boston Children's Hospital
Lloyd Paul Aiello
Lloyd Paul Aiello Harvard University
Napoleone Ferrara
Napoleone Ferrara University of California, San Diego
Nicholas Mitsiades
Nicholas Mitsiades Baylor College of Medicine
Iain L. Campbell
Iain L. Campbell University of Sydney
George D. Yancopoulos
George D. Yancopoulos Regeneron (United States)

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring healthcare careers doesn’t always require the traditional medical school route. There are many paths available to fit different interests and educational backgrounds. For example, those seeking entry into the rapidly growing healthcare sector can consider medical billing and coding financial aid options for online programs, helping to lower the barrier to entry in administrative roles.

Prospective nurses are often concerned about admission tests, but you might wonder, do you have to take the teas test to get into nursing school? Some nursing schools offer alternative pathways that do not require TEAS or HESI exams, making it easier to start your nursing journey.

For those interested in leadership roles, a healthcare administration associate degree online can open the door to management positions in hospitals, clinics, and other medical facilities.

Already a registered nurse? Fast-track your career growth with rn to fnp programs, bridging the gap between an associate degree and a master's level Family Nurse Practitioner qualification.

Best Scientists Citing Anthony P. Adamis

Trending Scientists

Recently Published Articles